Geoffrey M. Parker
Chief Financial Officer
CFO
Board Member
Executive changes
-
Appointed director to hold office until the 2027 Annual General Meeting of Shareholders at PERRIGO Co plc (PRGO)2026-04-30
Earnings-call appearances
-
Allogene Therapeutics, Inc. Q4 FY2025 Earnings Call2026-03-12
Allogene Therapeutics, Inc. (ALLO)
-
Allogene Therapeutics, Inc. Q3 FY2025 Earnings Call2025-11-06
Allogene Therapeutics, Inc. (ALLO)
-
Allogene Therapeutics, Inc. Q2 FY2025 Earnings Call2025-08-13
Allogene Therapeutics, Inc. (ALLO)